about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

NICE has 'done all we can' to ne­go­ti­ate for En­her­tu cov­er­age, reaf­firms de­ci­sion not to rec­om­mend

6 months ago
Pharma

BeiGene set­tles fi­nal suit over fu­ture Brukin­sa gener­ics

6 months ago
Pharma
Law

Drug­mak­ers 'not do­ing every­thing that they could' to widen glob­al ac­cess, new re­port finds

6 months ago
Pharma

Vir, Blue­jay in­vig­o­rate he­pati­tis D space with new da­ta

6 months ago
R&D

CSL Behring will close Cal­i­for­nia of­fice as part of shrink­ing ex vi­vo work

6 months ago
People
Cell/Gene Tx

Boston Phar­ma­ceu­ti­cals hits Phase 2 goals as it tries to keep up with MASH com­peti­tors

6 months ago
R&D

Gilead will close Philadel­phia, Seat­tle of­fices as part of job re­duc­tions

6 months ago
People
Pharma

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

6 months ago
Pharma

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

6 months ago
China
Pharma

In­ter­cept is de­nied full FDA ap­proval for Ocali­va, but claims it will keep drug on mar­ket

6 months ago
Pharma
FDA+

FDA lifts hold on No­vavax vac­cines af­ter ad­verse event re­clas­si­fied as ALS

6 months ago
R&D
Pharma

GSK leaves biotech trade group BIO

6 months ago
Pharma

Ei­sai slash­es Leqem­bi sales fore­cast by al­most $100M

6 months ago
Pharma

Se­nior As­traZeneca ex­ec de­tained in Chi­na amid wider in­ves­ti­ga­tion

6 months ago
People
China

Soft RSV sales re­veal a vac­cine mar­ket fail­ing to catch post-Covid mo­men­tum

6 months ago
Pharma
FDA+

Mod­er­na re­ports slow start to RSV sales as Ban­cel steps back from com­mer­cial role

6 months ago
People
Pharma

One biotech is look­ing to lessen an­tipsy­chot­ic-in­duced weight gain, de­spite new en­trants

6 months ago
R&D

Is there room for MASH drugs in a GLP-1 world?

6 months ago
R&D
Pharma

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

7 months ago
R&D

Com­pass Path­ways de­lays key Phase 3 psilo­cy­bin read­outs, spurring 30% lay­offs

7 months ago
R&D

Pfiz­er shares new de­tails on obe­si­ty pipeline, hints at ‘oth­er op­por­tu­ni­ties’

7 months ago
R&D
Pharma

Up­dat­ed: Pfiz­er’s Covid pill pow­ers guid­ance raise, but short­fall else­where rais­es ques­tions

7 months ago
Pharma

BeiGene ex­ec­u­tive re­port­ed­ly un­der in­ves­ti­ga­tion in Chi­na

7 months ago
China
Pharma

No­var­tis pays Monte Rosa $150M for Phase 1 drug in lat­est en­dorse­ment of mol­e­c­u­lar glues

7 months ago
Deals
First page Previous page 45678910 Next page Last page
A service from the Financial Times